Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 12/20 | 0.51 |
| ▸ | ITGAV | P06756 | 12/20 | 0.51 |
| ▸ | ITGB1 | P05556 | 5/20 | 0.51 |
| ▸ | ITGA5 | P08648 | 5/20 | 0.51 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.51 |
| ▸ | ITGB5 | P18084 | 3/20 | 0.48 |
| ▸ | MC4R | P32245 | 3/20 | 0.44 |
| ▸ | MC5R | P33032 | 3/20 | 0.44 |
| ▸ | MC3R | P41968 | 3/20 | 0.44 |
| ▸ | MC1R | Q01726 | 3/20 | 0.44 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.42 |
| ▸ | CTSG | P08311 | 1/20 | 0.42 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.41 |
| ▸ | ITGB6 | P18564 | 1/20 | 0.40 |
| ▸ | ITGB8 | P26012 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16177741 | 0.89 | ITGB3 (0.61) | ITGB3ITGAVITGB1ITGA5KEAP1 | |
| SCHEMBL14885782 | 0.89 | ITGB3 (0.61) | ITGB3ITGAVITGB1ITGA5KEAP1 | |
| SCHEMBL16188466 | 0.85 | ITGB3 (0.48) | ITGB3ITGAVITGB1ITGA5KEAP1 | |
| SCHEMBL16177739 | 0.84 | ITGB3 (0.54) | ITGB3ITGAVITGB1ITGA5KEAP1 | |
| SCHEMBL279121 | 0.82 | ITGB3 (0.64) | ITGB3ITGAVITGB1ITGA5KEAP1 | |
| SCHEMBL7744481 | 0.82 | ITGB3 (0.64) | ITGB3ITGAVITGB1ITGA5KEAP1 | |
| SCHEMBL16188489 | 0.81 | ITGAV (0.48) | ITGB3ITGAVITGB1ITGA5KEAP1 | |
| SCHEMBL14075705 | 0.78 | ITGB3 (0.53) | ITGB3ITGAVITGB1ITGA5KEAP1 | |
| SCHEMBL7743802 | 0.78 | ITGB3 (0.56) | ITGB3ITGAVITGB1ITGA5ITGB5 | |
| SCHEMBL22278847 | 0.78 | ITGB3 (0.52) | ITGB3ITGAVITGB1ITGA5KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9775803-B2 | Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-10-03 | — | — | US | disclosed |
| US-20170165198-A9 | LIPOSOME COMPRISING ELASTIN-LIKE POLYPEPTIDE AND TUMOR CELL TARGETING MATERIAL AND USE THEREOF | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170165198-A9 | LIPOSOME COMPRISING ELASTIN-LIKE POLYPEPTIDE AND TUMOR CELL TARGETING MATERIAL AND USE THEREOF | LNPEP, EBPL, LIPG | ITGB3 2998/4885ITGAV 2899/4885ITGB1 2810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.